{"id":62551,"date":"2026-01-28T04:06:08","date_gmt":"2026-01-28T03:06:08","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/nondrug-emotion-regulation-therapy-enters-pilot-program-as-federal-mental-health-system-faces-major-disruption\/"},"modified":"2026-01-28T04:06:08","modified_gmt":"2026-01-28T03:06:08","slug":"nondrug-emotion-regulation-therapy-enters-pilot-program-as-federal-mental-health-system-faces-major-disruption","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/nondrug-emotion-regulation-therapy-enters-pilot-program-as-federal-mental-health-system-faces-major-disruption\/","title":{"rendered":"Nondrug Emotion Regulation Therapy Enters Pilot Program as Federal Mental Health System Faces Major Disruption"},"content":{"rendered":"
\n

LAS VEGAS–(BUSINESS WIRE)–#BehavioralHealth<\/a>–As the U.S. mental health system faces sustained funding instability, workforce burnout, and rising demand for rapid, nonpharmaceutical support, JOYELY, LLC, an emotional regulation pilot program, is launching in California this February.<\/p>\n

<\/a>
<\/a><\/p>\n

\nThe timing reflects growing strain across the mental health ecosystem. Federal agencies and community providers have faced staffing disruptions and grant uncertainty, while public concern about emotional well-being continues to rise.<\/p>\n

\nThe JOY Intelligence\u2122 framework, formalized as Emotional Recognition Baseline Therapy (ERBT) for clinical application, developed by Sheryl Lynn and Bailey Romatoski, addresses what traditional systems often cannot: teaching leaders and professionals to regulate emotions under pressure, preventing communication breakdowns, therapist burnout, and escalating mental health crises.<\/p>\n

\nA pilot program using the JQ System and Integrated Valence Theory begins in February in California under the direction of Ehsan Gharadjedaghi Psy.D., Founder and Clinical Director of Norooz Clinic Foundation, a nonprofit mental health community center providing affordable behavioral healthcare and training for emerging therapists.<\/p>\n

\n“When clients learn to recognize and process emotions with structure and safety, therapy becomes less about reacting and more about navigating,” said Dr. Gharadjedaghi. “ERBT offers a science-informed way to reframe emotional experience and support lasting change.”<\/i><\/p>\n

\nInternal data from thousands of participants from previously conducted user experiences shows 94% reported immediate relief post-session. In a healthcare worker pilot (n\u224880), self-regulation scores improved 68% on average. These findings are being formally evaluated in the pilot program.<\/p>\n

\nGrounded in the patent-pending Integrated Valence Theory, the methodology begins with the Chair of JOY\u00ae, a 60-second guided practice to sit, breathe, think, and feel without judgment.<\/p>\n

\nPilot programs beginning in February will evaluate the framework’s application beyond suicide prevention, to workplace leadership, crisis communication, and the daily emotional regulation required to function under pressure. A public demonstration featuring 60 speakers takes place on January 28 in Las Vegas.<\/p>\n

\nJQ60 VOICES Event:
\n
<\/b>Wednesday, January 28, 2026
\n
Livestream:<\/b> https:\/\/joyely.com\/jq60\/<\/a><\/p>\n

\nFor more information:
\n
<\/b>JOYELY: https:\/\/joyely.com <\/a><\/p>\n

\nAbout <\/b><\/p>\n

\nChair of JOY, Inc. is a nonprofit organization operated exclusively for charitable and educational purposes.<\/p>\n

\nChair of JOY provides global support services that help individuals and families build emotional regulation skills that strengthen mental health, resilience, and connection. Its programs serve family-owned businesses, veterans, and seniors, focused on creating emotional safety, steady presence, and sustainable well-being across all stages of life.<\/p>\n

\nSOURCE: <\/b>JOYELY<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contact: <\/b>Victoria Ojuola
\n
victoria.ojuola@joyely.com<\/a>
949-303-5219<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

LAS VEGAS–(BUSINESS WIRE)–#BehavioralHealth–As the U.S. mental health system faces sustained funding instability, workforce burnout, and rising demand for rapid, nonpharmaceutical support, JOYELY, LLC, an emotional regulation pilot program, is launching in California this February. The timing reflects growing strain across the mental health ecosystem. Federal agencies and community providers have faced staffing disruptions and grant … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62551","6":"format-standard","7":"category-industry"},"yoast_head":"\nNondrug Emotion Regulation Therapy Enters Pilot Program as Federal Mental Health System Faces Major Disruption - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/nondrug-emotion-regulation-therapy-enters-pilot-program-as-federal-mental-health-system-faces-major-disruption\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nondrug Emotion Regulation Therapy Enters Pilot Program as Federal Mental Health System Faces Major Disruption - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LAS VEGAS–(BUSINESS WIRE)–#BehavioralHealth–As the U.S. mental health system faces sustained funding instability, workforce burnout, and rising demand for rapid, nonpharmaceutical support, JOYELY, LLC, an emotional regulation pilot program, is launching in California this February. The timing reflects growing strain across the mental health ecosystem. Federal agencies and community providers have faced staffing disruptions and grant ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/nondrug-emotion-regulation-therapy-enters-pilot-program-as-federal-mental-health-system-faces-major-disruption\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-28T03:06:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260127009923\/en\/2703994\/22\/Official_Emotions_Map.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nondrug-emotion-regulation-therapy-enters-pilot-program-as-federal-mental-health-system-faces-major-disruption\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nondrug-emotion-regulation-therapy-enters-pilot-program-as-federal-mental-health-system-faces-major-disruption\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Nondrug Emotion Regulation Therapy Enters Pilot Program as Federal Mental Health System Faces Major Disruption\",\"datePublished\":\"2026-01-28T03:06:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nondrug-emotion-regulation-therapy-enters-pilot-program-as-federal-mental-health-system-faces-major-disruption\\\/\"},\"wordCount\":411,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nondrug-emotion-regulation-therapy-enters-pilot-program-as-federal-mental-health-system-faces-major-disruption\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260127009923\\\/en\\\/2703994\\\/22\\\/Official_Emotions_Map.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nondrug-emotion-regulation-therapy-enters-pilot-program-as-federal-mental-health-system-faces-major-disruption\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nondrug-emotion-regulation-therapy-enters-pilot-program-as-federal-mental-health-system-faces-major-disruption\\\/\",\"name\":\"Nondrug Emotion Regulation Therapy Enters Pilot Program as Federal Mental Health System Faces Major Disruption - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nondrug-emotion-regulation-therapy-enters-pilot-program-as-federal-mental-health-system-faces-major-disruption\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nondrug-emotion-regulation-therapy-enters-pilot-program-as-federal-mental-health-system-faces-major-disruption\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260127009923\\\/en\\\/2703994\\\/22\\\/Official_Emotions_Map.jpg\",\"datePublished\":\"2026-01-28T03:06:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nondrug-emotion-regulation-therapy-enters-pilot-program-as-federal-mental-health-system-faces-major-disruption\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nondrug-emotion-regulation-therapy-enters-pilot-program-as-federal-mental-health-system-faces-major-disruption\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nondrug-emotion-regulation-therapy-enters-pilot-program-as-federal-mental-health-system-faces-major-disruption\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260127009923\\\/en\\\/2703994\\\/22\\\/Official_Emotions_Map.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260127009923\\\/en\\\/2703994\\\/22\\\/Official_Emotions_Map.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nondrug-emotion-regulation-therapy-enters-pilot-program-as-federal-mental-health-system-faces-major-disruption\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nondrug Emotion Regulation Therapy Enters Pilot Program as Federal Mental Health System Faces Major Disruption\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nondrug Emotion Regulation Therapy Enters Pilot Program as Federal Mental Health System Faces Major Disruption - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/nondrug-emotion-regulation-therapy-enters-pilot-program-as-federal-mental-health-system-faces-major-disruption\/","og_locale":"en_US","og_type":"article","og_title":"Nondrug Emotion Regulation Therapy Enters Pilot Program as Federal Mental Health System Faces Major Disruption - Pharma Trend","og_description":"LAS VEGAS–(BUSINESS WIRE)–#BehavioralHealth–As the U.S. mental health system faces sustained funding instability, workforce burnout, and rising demand for rapid, nonpharmaceutical support, JOYELY, LLC, an emotional regulation pilot program, is launching in California this February. The timing reflects growing strain across the mental health ecosystem. Federal agencies and community providers have faced staffing disruptions and grant ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/nondrug-emotion-regulation-therapy-enters-pilot-program-as-federal-mental-health-system-faces-major-disruption\/","og_site_name":"Pharma Trend","article_published_time":"2026-01-28T03:06:08+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260127009923\/en\/2703994\/22\/Official_Emotions_Map.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/nondrug-emotion-regulation-therapy-enters-pilot-program-as-federal-mental-health-system-faces-major-disruption\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/nondrug-emotion-regulation-therapy-enters-pilot-program-as-federal-mental-health-system-faces-major-disruption\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Nondrug Emotion Regulation Therapy Enters Pilot Program as Federal Mental Health System Faces Major Disruption","datePublished":"2026-01-28T03:06:08+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/nondrug-emotion-regulation-therapy-enters-pilot-program-as-federal-mental-health-system-faces-major-disruption\/"},"wordCount":411,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/nondrug-emotion-regulation-therapy-enters-pilot-program-as-federal-mental-health-system-faces-major-disruption\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260127009923\/en\/2703994\/22\/Official_Emotions_Map.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/nondrug-emotion-regulation-therapy-enters-pilot-program-as-federal-mental-health-system-faces-major-disruption\/","url":"https:\/\/pharma-trend.com\/en\/nondrug-emotion-regulation-therapy-enters-pilot-program-as-federal-mental-health-system-faces-major-disruption\/","name":"Nondrug Emotion Regulation Therapy Enters Pilot Program as Federal Mental Health System Faces Major Disruption - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/nondrug-emotion-regulation-therapy-enters-pilot-program-as-federal-mental-health-system-faces-major-disruption\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/nondrug-emotion-regulation-therapy-enters-pilot-program-as-federal-mental-health-system-faces-major-disruption\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260127009923\/en\/2703994\/22\/Official_Emotions_Map.jpg","datePublished":"2026-01-28T03:06:08+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/nondrug-emotion-regulation-therapy-enters-pilot-program-as-federal-mental-health-system-faces-major-disruption\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/nondrug-emotion-regulation-therapy-enters-pilot-program-as-federal-mental-health-system-faces-major-disruption\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/nondrug-emotion-regulation-therapy-enters-pilot-program-as-federal-mental-health-system-faces-major-disruption\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260127009923\/en\/2703994\/22\/Official_Emotions_Map.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260127009923\/en\/2703994\/22\/Official_Emotions_Map.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/nondrug-emotion-regulation-therapy-enters-pilot-program-as-federal-mental-health-system-faces-major-disruption\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Nondrug Emotion Regulation Therapy Enters Pilot Program as Federal Mental Health System Faces Major Disruption"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62551","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62551"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62551\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62551"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62551"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62551"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}